T/CMBA 021-2023 Active Group standards

T/CMBA 021-2023 Quality Management Specification for Raw Materials Used in Cell Therapy Product Manufacturing

Publish Date: 2023-09-14 Implement Date: 2023-09-14 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Download

Basic Information

Standard Code: T/CMBA 021-2023

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Integrated medical science and healthcare devices

Publish Date: 2023-09-14

Implement Date: 2023-09-14

Scope

Main technical content: This document sets out the quality requirements for raw materials used in the production of cell therapy products, as well as the unique characteristics and quality requirements of certain specific components or types of raw materials used in production, such as serum and serum substitutes, recombinant proteins, and tissue extract proteins, etc.

Development Information

Related Standards

GB 3232-1982 Abolished

GB 3232-1982 Diagnostic criteria and principles of management of occupational chronic manganism

Publish Date: 1982-10-25

GB 3233-1982 Abolished

GB 3233-1982 Diagnostic criteria and principles of management of occupational chronic carbon disulfide poisoning

Publish Date: 1982-10-25

GB 3234-1982 Abolished

GB 3234-1982 Diagnostic criteria and principles of management of industrial fluorosis

Publish Date: 1982-10-25

GB 4865-1985 Abolished

GB 4865-1985 Diagnostic criteria and principles of management of occupational chronic allyl chloride poisoning

Publish Date: 1985-01-14

GB 4869-1985 Abolished

GB 4869-1985 Diagnostic criteria and principles of management of occupational vibration disease

Publish Date: 1985-01-14

GB 5044-1985 Abolished

GB 5044-1985 Classification of health hazard levels from occupational exposure to toxic substances

Publish Date: 1985-04-02